Skip to main content
. 2020 Nov 27;8(2):e001856. doi: 10.1136/bmjdrc-2020-001856

Figure 3.

Figure 3

Duration from initiation of treatment with sodium-glucose cotransporter 2 (SGLT2) inhibitor to the onset of hypoglycemia.